Cystic Fibrosis Nutrition Products Market

High-calorie high-protein ONS is estimated at 43.5% of product type revenue in 2026, with pediatric at 47.4% by age group and RTD at 43.4% by product form. Adoption depends on dietitian-directed calorie replacement and repeat home access, but wider weight variation and payer rules limit one-format purchasing.